Purdue Pharma denies EY conflicts of interest, fraudulent transfers

Bankrupt US OxyContin maker Purdue Pharma has denied claims its plan to hire EY would create a conflict of interest, as it fights fraudulent transfer claims raised in the US Supreme Court.

Get unlimited access to all Global Restructuring Review content